Stivarou T - Search Results

1

The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming.

Marzi I, Cipolleschi MG, D'Amico M, Stivarou T, Rovida E, Vinci MC, Pandolfi S, Dello Sbarba P, Stecca B, Olivotto M. Marzi I, et al. Among authors: stivarou t. Cell Cycle. 2013 Jan 15;12(2):353-64. doi: 10.4161/cc.23200. Epub 2012 Jan 15. Cell Cycle. 2013. PMID: 23287475 Free PMC article.

2

Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets.

Cipolleschi MG, Marzi I, Santini R, Fredducci D, Vinci MC, D'Amico M, Rovida E, Stivarou T, Torre E, Dello Sbarba P, Stecca B, Olivotto M. Cipolleschi MG, et al. Among authors: stivarou t. Cell Cycle. 2014;13(2):268-78. doi: 10.4161/cc.27031. Epub 2013 Nov 5. Cell Cycle. 2014. PMID: 24200964 Free PMC article.

3

The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents.

Stivarou T, Cipolleschi MG, D'Amico M, Mannini A, Mini E, Rovida E, Dello Sbarba P, Olivotto M, Marzi I. Stivarou T, et al. Oncotarget. 2015 Oct 13;6(31):31985-96. doi: 10.18632/oncotarget.5155. Oncotarget. 2015. PMID: 26396171 Free PMC article.

4

Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.

Stivarou T, Stellas D, Vartzi G, Thomaidou D, Patsavoudi E. Stivarou T, et al. Cancer Biol Ther. 2016 Aug 2;17(8):799-812. doi: 10.1080/15384047.2016.1195041. Epub 2016 Jun 3. Cancer Biol Ther. 2016. PMID: 27259689 Free PMC article.

5

Extracellular molecules involved in cancer cell invasion.

Stivarou T, Patsavoudi E. Stivarou T, et al. Cancers (Basel). 2015 Jan 26;7(1):238-65. doi: 10.3390/cancers7010238. Cancers (Basel). 2015. PMID: 25629807 Free PMC article. Review.

6

Toward fully exploiting the therapeutic potential of marketed pharmaceuticals: the use of octreotide and chloroquine in oncology.

Papanagnou P, Papadopoulos GE, Stivarou T, Pappas A. Papanagnou P, et al. Among authors: stivarou t. Onco Targets Ther. 2018 Dec 31;12:319-339. doi: 10.2147/OTT.S182685. eCollection 2019. Onco Targets Ther. 2018. PMID: 30643430 Free PMC article. Review.

7

Marketed drugs used for the management of hypercholesterolemia as anticancer armament.

Papanagnou P, Stivarou T, Papageorgiou I, Papadopoulos GE, Pappas A. Papanagnou P, et al. Among authors: stivarou t. Onco Targets Ther. 2017 Sep 8;10:4393-4411. doi: 10.2147/OTT.S140483. eCollection 2017. Onco Targets Ther. 2017. PMID: 28932124 Free PMC article. Review.

8

New Analogs of Polyamine Toxins from Spiders and Wasps: Liquid Phase Fragment Synthesis and Evaluation of Antiproliferative Activity.

Vassileiou C, Kalantzi S, Vachlioti E, Athanassopoulos CM, Koutsakis C, Piperigkou Z, Karamanos N, Stivarou T, Lymberi P, Avgoustakis K, Papaioannou D. Vassileiou C, et al. Among authors: stivarou t. Molecules. 2022 Jan 10;27(2):447. doi: 10.3390/molecules27020447. Molecules. 2022. PMID: 35056762 Free PMC article.

9

The Role of miRNAs in Common Inflammatory Arthropathies: Osteoarthritis and Gouty Arthritis.

Papanagnou P, Stivarou T, Tsironi M. Papanagnou P, et al. Among authors: stivarou t. Biomolecules. 2016 Nov 11;6(4):44. doi: 10.3390/biom6040044. Biomolecules. 2016. PMID: 27845712 Free PMC article. Review.

10

Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs.

Papanagnou P, Stivarou T, Tsironi M. Papanagnou P, et al. Among authors: stivarou t. Pharmaceuticals (Basel). 2016 May 6;9(2):24. doi: 10.3390/ph9020024. Pharmaceuticals (Basel). 2016. PMID: 27164115 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters